Effects of immunization against PCSK9 in an experimental model of breast cancer

INTRODUCTION: Inhibition of proprotein convertase subtilisin/kexin 9 (PCSK9) is an efficient strategy for lowering low-density lipoprotein cholesterol (LDL-C). There are, however, scant data on the efficacy and safety of PCSK9 inhibitors in non-cardiovascular diseases, particularly cancer. The prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Momtazi-Borojeni, Amir Abbas, Nik, Maryam Ebrahimi, Jaafari, Mahmoud Reza, Banach, Maciej, Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Hot Topics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524183/
https://www.ncbi.nlm.nih.gov/pubmed/31110521
http://dx.doi.org/10.5114/aoms.2019.84734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524183/
https://www.ncbi.nlm.nih.gov/pubmed/31110521
http://dx.doi.org/10.5114/aoms.2019.84734

Ejemplares similares